Back to top

Image: Bigstock

Top Ranked Growth Stocks to Buy for September 14th

Read MoreHide Full Article

Here are four stocks with buy ranks and strong growth characteristics for investors to consider today, September 14th:

Hibbett Sports, Inc. (HIBB - Free Report) : This retailer of athletic-inspired fashion products, which carries a Zacks Rank #1 (Strong Buy), has witnessed the Zacks Consensus Estimate for its current year earnings increasing more than 100% over the last 60 days.

Hibbett Sports, Inc. Price and Consensus

Hibbett Sports has a PEG ratio of 0.63, compared with 2.56 for the industry. The company possesses a Growth Score of A.

Hibbett Sports, Inc. PEG Ratio (TTM)

Meritage Homes Corporation (MTH - Free Report) : This designer and builder of single-family homes, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 50.6% over the last 60 days.

Meritage Homes Corporation Price and Consensus

Meritage Homes has a PEG ratio 0.59, compared with 1.23 for the industry. The company possesses a Growth Score of A.

Meritage Homes Corporation PEG Ratio (TTM)

JD.com, Inc. (JD - Free Report) : This e-commerce company and retail infrastructure service provider in China, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 20.8% over the last 60 days.

JD.com, Inc. Price and Consensus

JD.com has a PEG ratio 0.99, compared with 20.82 for the industry. The company possesses a Growth Score of A.

JD.com, Inc. PEG Ratio (TTM)

Target Corporation (TGT - Free Report) : This general merchandise retailer, which carries a Zacks Rank #1, has witnessed the Zacks Consensus Estimate for its current year earnings increasing 44.2% over the last 60 days.

Target Corporation Price and Consensus

Target has a PEG ratio 2.86, compared with 5.12 for the industry. The company possesses a Growth Score of A.

Target Corporation PEG Ratio (TTM)

See the full list of top ranked stocks here

Learn more about the Growth score and how it is calculated here.

Breakout Biotech Stocks with Triple-Digit Profit Potential

The biotech sector is projected to surge beyond $775 billion by 2024 as scientists develop treatments for thousands of diseases. They’re also finding ways to edit the human genome to literally erase our vulnerability to these diseases.

Zacks has just released Century of Biology: 7 Biotech Stocks to Buy Right Now to help investors profit from 7 stocks poised for outperformance. Our recent biotech recommendations have produced gains of +50%, +83% and +164% in as little as 2 months. The stocks in this report could perform even better.

See these 7 breakthrough stocks now>>